Investigation of the dosimetric impact of a Ni-Ti fiducial marker in carbon ion and proton beams

Acta Oncologica

Volumn 49, Issue 7, 2010, Pages 1160-1164

  Herrmann, Rochus ^a,b   Carl, Jesper ^c   Jäkel, Oliver ^d,e   Bassler, Niels ^a,b   Petersen, Jørgen B B ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON; NICKEL; PROTON; TITANIUM;

ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; DOSIMETRY; ION THERAPY; MONTE CARLO METHOD; PRIORITY JOURNAL; PROTON THERAPY; RADIATION FIELD; SIMULATION; STENT; TREATMENT PLANNING;

CARBON; CARCINOMA; COMPUTER SIMULATION; CONE-BEAM COMPUTED TOMOGRAPHY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FIDUCIAL MARKERS; HUMANS; IONS; MALE; MODELS, BIOLOGICAL; NICKEL; PROSTATIC NEOPLASMS; PROTONS; RADIATION DOSAGE; RADIOMETRY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; STENTS; TITANIUM; WATER;

EID: 77956576834     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2010.505934     Document Type: Article

References (14)

1. Kuban DA, Tucker SL, Dong L, Starkschall G, Huang EH, Cheung MR, et al. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Biol Phys 2008;70:67-74.
2. Poulsen PR, Muren LP, Høyer M. Residual set-up errors and margins in on-line image-guided prostate localization in radiotherapy. Radiother Oncol 2007;85:201-206
3. Jäkel O, Reiss P. The influence of metal artefacts on the range of ion beams. Phys Med Biol 2007;52:635-644
4. Newhauser W, Fontenot J, Koch N, Dong L, Lee A, Zheng Y, et al. Monte Carlo simulations of the dosimetric impact of radiopaque fi ducial markers for proton radiotherapy of the prostate. Phys Med Biol 2007;52:2937-2952
5. Miyamoto T, Yamamoto N, Nishimaura H, Koto M, Tsuji H, Mizoe J, et al. Carbon ion radiotherapy for stage I non-small cell lung cancer. Radiother Oncol 2002;66:127-140
6. Lim YK, Kwak J, Kim DW, Shin D, Yoon M, Park S, et al. Microscopic gold particle-based fi ducial markers for proton therapy of prostate cancer. Int J Radiat Oncol Biol Phys 2009;74:1609-1616
7. Carl J, Nielsen J, Holmberg M, Larsen EH, Fabrin K, Fisker RV. A new fiducial marker for image-guided radiotherapy of prostate cancer: Clinical experience. Acta Oncol 2008;47: 1358-1366
8. Carl J, Lund B, Larsen EH, Nielsen J. Feasibility study using a Ni-Ti stent and electronic portal imaging to localize the prostate during radiotherapy. Radiother Oncol 2006;78: 199-206.
9. Battistoni G, Muraro S, Sala PR, Cerutti F, Ferrari A, Roesler S, et al. FLUKA: A multi-particle transport code. In: Albrow M, Raja R, editors. Proceedings of the Hadronic Shower Simulation Workshop, Fermilab; 2006 Sep 6-8. AIP Conference Proceeding 2007;896:31-49.
10. Sommerer F, Parodi K, Ferrari A, Poljanc K, Enghardt W, Aiginger H. Investigating the accuracy of the FLUKA code for transport of therapeutic ion beams in matter. Phys Med Biol 2006;51:4385-4398
11. Parodi K, Enghardt W, Haberer T. In-beam PET measurements of P+ radioactivity induced by proton beams. Phys Med Biol 2002;47:21-36.
12. Roesler S, Engel R, Ranft J. The Monte Carlo event generator DPMJET-III. In: Kling A, Barao F, Nakagawa M, Tavora L, Vaz P, editors. Proceedings Monte Carlo 2000 Conference; 2000 Oct 23-26; Lisbon. Berlin: Springer-Verlag; 2001. pp. 1033-1038
13. Krämer M, Jäkel O, Haberer T, Kraft G, Schardt D, Weber U. Treatment planning for heavy-ion radiotherapy: Physical beam model and dose optimization. Phys Med Biol 2000;45: 3299-3317
14. Isacsson U, Nilsson K, Asplund S, Morhed E, Montelius A, Turesson I. A method to separate the rectum from the prostate during proton beam radiotherapy of prostate cancer patients. Acta Oncol 2010;49:500-505